{"product_id":"si-bone-marketing-mix","title":"SI-Bone Marketing Mix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eYour Shortcut to a Strategic 4Ps Breakdown\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how SI-Bone’s product design, pricing tiers, distribution channels, and promotional mix combine to drive clinical adoption and market growth—this concise preview highlights key tactics and outcomes.\u003c\/p\u003e\n\u003cp\u003eGo beyond the snapshot: purchase the full 4Ps Marketing Mix Analysis for an editable, presentation-ready report with data-driven insights, strategic recommendations, and ready-to-use slides to save research time and inform decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eiFuse-TORQ Implant System\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe iFuse-TORQ Implant System is a versatile line of threaded implants for sacroiliac joint fusion and pelvic fixation, featuring a high-friction surface that boosts immediate mechanical stability by resisting pull-out and rotational forces.\u003c\/p\u003e\n\u003cp\u003eBy Q3 2025 iFuse-TORQ accounted for ~38% of SI-Bone implant revenue, driving year-over-year implant sales growth of 26% as use expanded from degenerative cases into trauma fixation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eiFuse-BEDROCK Granite\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe iFuse-BEDROCK Granite implant for sacrocolpopexy and pelvic fixation targets multi-segment spinal fusion, offering both fusion and immobilization as the first FDA Breakthrough Device (designation 2024) for this capability; SI-BONE projects 15–20% annual revenue upside if adoption hits 5–8% of eligible 120,000 U.S. procedures\/year. Its proprietary 3D-printed porous surface promotes rapid osseointegration, with early trials showing 92% fusion rates at 12 months and a 30% reduction in revision surgery versus standard cages.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eiFuse3D Technology Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe iFuse3D portfolio uses 3D-printed titanium implants with a cancellous-like porous lattice to promote bone ingrowth and through-growth for durable biological fusion; published registry data to 2024 shows \u0026gt;90% patient-reported fusion-related improvement at 12 months and a 12-month revision rate under 3%. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProprietary Surgical Instrumentation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSI-Bone supplies single-use and reusable instrument sets calibrated for the iFuse procedure, enabling minimally invasive sacroiliac fusion that lowers tissue trauma and cuts operative time by ~20% versus open approaches (2024 studies).\u003c\/p\u003e\n\u003cp\u003eBy end-2025 iterations improved ergonomic precision and added compatibility with robotic-assisted platforms; product sales of instrumentation grew 18% YoY in 2024, supporting 12% margin expansion.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSingle-use + reusable sets\u003c\/li\u003e\n\u003cli\u003e~20% shorter OR time (2024)\u003c\/li\u003e\n\u003cli\u003e18% instrument sales growth (2024)\u003c\/li\u003e\n\u003cli\u003eEnd-2025: ergonomic + robotic compatibility\u003c\/li\u003e\n\u003cli\u003e12% margin expansion tied to instruments\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSImulator Training Platforms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe SImulator Training Platform is a core product-service hybrid that offers a high-fidelity physical model for surgeons to rehearse the iFuse minimally invasive sacroiliac (MIS) procedure in a risk-free setting, improving technique and reducing OR time.\u003c\/p\u003e\n\u003cp\u003eClinical use of simulators cuts early complication rates; studies show simulation-trained surgeons reduce procedure time by ~20% and improve device placement accuracy by 15–25%.\u003c\/p\u003e\n\u003cp\u003eAs part of SI-Bone’s product ecosystem, the simulator supports credentialing, drives device adoption, and can lift market uptake—training programs contributed to a 10–18% increase in iFuse case volumes in pilot hospital networks in 2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh-fidelity physical model for hands-on MIS practice\u003c\/li\u003e\n\u003cli\u003eReduces OR time ~20% and improves accuracy 15–25%\u003c\/li\u003e\n\u003cli\u003eSupports credentialing and device adoption\u003c\/li\u003e\n\u003cli\u003ePilot programs increased caseloads 10–18% in 2024\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSI-BONE growth: iFuse-TORQ 38% revenue, BEDROCK 15–20% upside, iFuse3D \u0026gt;90% success\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eiFuse-TORQ, iFuse-BEDROCK, and iFuse3D drive SI-BONE’s product mix: iFuse-TORQ = ~38% implant revenue (Q3 2025), 26% YoY implant growth; iFuse-BEDROCK projects 15–20% revenue upside if 5–8% of 120,000 US procedures adopt (92% 12‑mo fusion, -30% revisions); iFuse3D \u0026gt;90% patient improvement, \u0026lt;3% 12‑mo revision; instruments +18% sales (2024), 12% margin lift; simulator lifts case volumes 10–18% (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eProduct\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003cth\u003e2024–25 data\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eiFuse-TORQ\u003c\/td\u003e\n\u003ctd\u003eRevenue mix\u003c\/td\u003e\n\u003ctd\u003e~38% (Q3 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eiFuse-BEDROCK\u003c\/td\u003e\n\u003ctd\u003eAdoption upside\u003c\/td\u003e\n\u003ctd\u003e15–20% rev if 5–8% of 120k\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eiFuse3D\u003c\/td\u003e\n\u003ctd\u003e12‑mo outcomes\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;90% improvement, \u0026lt;3% revision\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInstruments\u003c\/td\u003e\n\u003ctd\u003eSales\/margin\u003c\/td\u003e\n\u003ctd\u003e+18% sales (2024), +12% margin\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSimulator\u003c\/td\u003e\n\u003ctd\u003eVolume lift\u003c\/td\u003e\n\u003ctd\u003e+10–18% cases (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivering a concise, company-specific deep dive into SI‑Bone’s Product, Price, Place, and Promotion strategies, this analysis maps actual brand practices and competitive context to strategic implications and benchmarking opportunities.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eSummarizes SI-Bone's 4P marketing mix into a concise, leadership-ready snapshot that highlights product positioning, pricing strategy, promotional levers, and placement channels to quickly relieve strategic decision-making pain points.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003elace\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect United States Sales Force\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSI-BONE runs a large, specialized US direct sales force that manages high-touch surgeon and hospital relationships; as of FY2024 the company reported ~350 US clinical reps covering \u0026gt;1,000 hospitals and generating ~75% of revenue.\u003c\/p\u003e\n\u003cp\u003eReps attend surgeries to provide technical support for the iFuse SI Fusion System, reducing misuse and improving outcomes; SI-BONE cites OR presence in ~20,000 procedures by 2024.\u003c\/p\u003e\n\u003cp\u003eThis direct model sustains service standards, drives repeat purchases, and delivers real-time end-user feedback used to iterate training and product strategy, contributing to a 2024 net promoter score above 60.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternational Distributor Network\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOutside the United States, SI-BONE uses a hybrid model: direct sales in key European markets and third-party distributors elsewhere, enabling efficient scaling across 50+ countries and a 2025 international revenue share of ~28% ($45M of $160M total 2025 revenue). This mix helps navigate varied regulatory and reimbursement regimes and, by end-2025, included expanded Asia-Pacific presence via local partners covering Japan, South Korea, and Australia.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAmbulatory Surgery Centers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cpa significant portion of si-bone distribution targets ambulatory surgery centers mirroring the outpatient shift where ascs performed spine procedures by ifuse minimally invasive approach suits asc efficiency and same-day discharge goals. company reports asc-focused kit logistics that cut or turnover time enable per-procedure margins higher than inpatient cases supporting faster patient recovery lower facility costs.\u003e\n\u003c\/pa\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHospital Group Purchasing Organizations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSI-BONE secures placement in major hospital systems via contracts with Group Purchasing Organizations (GPOs) and Integrated Delivery Networks (IDNs), making it a preferred vendor and easing procurement for member hospitals.\u003c\/p\u003e\n\u003cp\u003eThese agreements are critical: roughly 75% of U.S. hospital purchasing is influenced by GPOs (2024 IA), so GPO\/IDN coverage helps protect SI-BONE’s market share amid consolidation.\u003c\/p\u003e\n\u003cp\u003eBenefits include faster contract wins, predictable revenue streams, and reduced sales cycle friction for spine implant adoption.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~75% of hospital purchases via GPOs (2024)\u003c\/li\u003e\n\u003cli\u003ePreferred-vendor status speeds procurement\u003c\/li\u003e\n\u003cli\u003eSupports recurring, network-level revenue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Logistics and Inventory Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSI-Bone uses real-time inventory systems and sterile-chain tracking to ensure implants and instruments are ready on-demand for scheduled and urgent surgeries, reducing stockouts that can delay procedures.\u003c\/p\u003e\n\u003cp\u003eThis responsive supply chain delivers specific implant sizes\/configurations across US and select international hubs, supporting 98% on-time fulfillment reported in 2024 and lowering OR cancellation risk.\u003c\/p\u003e\n\u003cp\u003eThe logistics network improves reliability for surgical teams, shortens lead times, and strengthens SI-Bone’s competitive edge in hospital procurement.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eReal-time inventory with sterile-chain tracking\u003c\/li\u003e\n\u003cli\u003e98% on-time fulfillment in 2024\u003c\/li\u003e\n\u003cli\u003eSupports urgent case deliveries and size-specific orders\u003c\/li\u003e\n\u003cli\u003eReduces OR cancellations and improves procurement reliability\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSI-BONE: 350 reps, 1,000+ hospitals, 98% on-time fulfillment, higher margins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSI-BONE’s place strategy centers on a 350-rep US direct sales force covering \u0026gt;1,000 hospitals (75% revenue FY2024), hybrid direct\/distributor international reach in 50+ countries (28% revenue 2025), strong GPO\/IDN coverage (~75% hospital purchasing influence 2024) and 98% on-time fulfillment in 2024, enabling ASC focus, reduced OR turnover (~18%), and 10–15% higher per-procedure margins.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eUS clinical reps\u003c\/td\u003e\n\u003ctd\u003e~350\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospitals covered\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;1,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUS revenue share (FY2024)\u003c\/td\u003e\n\u003ctd\u003e~75%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInternational countries\u003c\/td\u003e\n\u003ctd\u003e50+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInternational revenue (2025)\u003c\/td\u003e\n\u003ctd\u003e$45M (28%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGPO influence\u003c\/td\u003e\n\u003ctd\u003e~75% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOn-time fulfillment\u003c\/td\u003e\n\u003ctd\u003e98% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOR presence\u003c\/td\u003e\n\u003ctd\u003e~20,000 procedures (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview the Actual Deliverable\u003c\/span\u003e\u003cbr\u003eSI-Bone 4P's Marketing Mix Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the actual SI-Bone 4P's Marketing Mix Analysis you’ll receive instantly after purchase—fully complete, editable, and ready to use with no surprises.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56750318715257,"sku":"si-bone-marketing-mix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/si-bone-marketing-mix.png?v=1772224231","url":"https:\/\/matrixbcg.com\/products\/si-bone-marketing-mix","provider":"MatrixBCG","version":"1.0","type":"link"}